Reader View AI Reader View Novo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 Outlook www.nasdaq.com · November 4, 2026 · 07:11 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link